Wang N - Search Results

1

LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis.

Wei WS, Wang N, Deng MH, Dong P, Liu JY, Xiang Z, Li XD, Li ZY, Liu ZH, Peng YL, Li Z, Jiang LJ, Yao K, Ye YL, Lu WH, Zhang ZL, Zhou FJ, Liu ZW, Xie D, Yu CP. Wei WS, et al. Among authors: wang n. Redox Biol. 2021 Nov 27;48:102201. doi: 10.1016/j.redox.2021.102201. Online ahead of print. Redox Biol. 2021. PMID: 34864630 Free PMC article.

2

FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.

Deng M, Wang N, Li Z, Chen R, Duan J, Peng Y, Wu Z, Zhang Z, Jiang L, Zheng X, Xie D, Wei W, Liu Z, Zhou F. Deng M, et al. Among authors: wang n. Cell Death Dis. 2022 Feb 22;13(2):170. doi: 10.1038/s41419-022-04614-1. Cell Death Dis. 2022. PMID: 35194031 Free PMC article.

3

ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.

Deng M, Wei W, Duan J, Chen R, Wang N, He L, Peng Y, Ma X, Wu Z, Liu J, Li Z, Zhang Z, Jiang L, Zhou F, Xie D. Deng M, et al. Among authors: wang n. Cancer Sci. 2021 May;112(5):1758-1771. doi: 10.1111/cas.14810. Epub 2021 Mar 9. Cancer Sci. 2021. PMID: 33440047 Free PMC article.

4

Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis.

Wu Z, Peng Y, Xiong L, Wang J, Li Z, Ning K, Deng M, Wang N, Wei W, Li Z, Dong P, Yu C, Zhou F, Zhang Z. Wu Z, et al. Among authors: wang j, wang n. Cancer Med. 2022 Oct;11(19):3674-3686. doi: 10.1002/cam4.4743. Epub 2022 Apr 10. Cancer Med. 2022. PMID: 35476809 Free PMC article.

5

SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7.

Wang L, Zhang Q, Wu P, Xiang W, Xie D, Wang N, Deng M, Cao K, Zeng H, Xu Z, Xiaoming Liu, He L, Long Z, Tan J, Wang J, Liu B, Liu J. Wang L, et al. Among authors: wang j, wang n. Cancer Sci. 2020 Jul;111(7):2349-2360. doi: 10.1111/cas.14502. Epub 2020 Jun 13. Cancer Sci. 2020. PMID: 32449280 Free PMC article.

6

Single-cell transcriptomics reveals a low CD8⁺ T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma.

Peng YL, Xiong LB, Zhou ZH, Ning K, Li Z, Wu ZS, Deng MH, Wei WS, Wang N, Zou XP, He ZS, Huang JW, Luo JH, Liu JY, Jia N, Cao Y, Han H, Guo SJ, Dong P, Yu CP, Zhou FJ, Zhang ZL. Peng YL, et al. Among authors: wang n. J Immunother Cancer. 2022 Feb;10(2):e004206. doi: 10.1136/jitc-2021-004206. J Immunother Cancer. 2022. PMID: 35121646 Free PMC article.

7

Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study.

Wang N, Ye Y, Deng M, Zhao D, Jiang L, Chen D, Wu Z, Wang Y, Li Z, Yang Z, Li J, Zhou F, Li Y. Wang N, et al. Among authors: wang y. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):837-844. doi: 10.1038/s41391-021-00335-2. Epub 2021 Mar 4. Prostate Cancer Prostatic Dis. 2021. PMID: 33664457 Free PMC article.

8

Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA.

Yu C, Zhang Y, Wang N, Wei W, Cao K, Zhang Q, Ma P, Xie D, Wu P, Liu B, Liu J, Xiang W, Hu X, Liu X, Xie J, Tang J, Long Z, Wang L, Zeng H, Liu J. Yu C, et al. Among authors: wang l, wang n. Biomater Res. 2022 Feb 5;26(1):6. doi: 10.1186/s40824-022-00251-z. Biomater Res. 2022. PMID: 35123588 Free PMC article.

9

Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade.

Wang N, Liu JY, Li X, Deng MH, Long Z, Tang J, Yao K, Zhang YC, He LY. Wang N, et al. Asian J Androl. 2018 Jul 17;21(1):56-61. doi: 10.4103/aja.aja_50_18. Online ahead of print. Asian J Androl. 2018. PMID: 30027930 Free PMC article.

10

Clinical value of normal saline injection for expansion of the anterior perirectal space during prostate cryoablation.

Wang N, Zhao DW, Chen D, Wu ZM, Wang YJ, Yang ZY, Zhao JL, Zhou FJ, Li YH. Wang N, et al. Among authors: wang yj. Eur J Surg Oncol. 2023 Jan;49(1):252-256. doi: 10.1016/j.ejso.2022.06.032. Epub 2022 Jun 27. Eur J Surg Oncol. 2023. PMID: 35817633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,094 results

Search Page